anti-FLT-3/CD135/FLK-2 antibody product blog
Tags: Antibody; Monoclonal Antibody; FLT-3/CD135/FLK-2; anti-FLT-3/CD135/FLK-2 antibody;
The FLT-3/CD135/FLK-2 n/a (Catalog #MBS2543387) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Mouse anti Human FLT-3/CD135/FLK-2 Monoclonal Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s FLT-3/CD135/FLK-2 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA).ELISA: 0.5-1 mug/mL. This antibody can be used at 0.5-1 mug/mL with the appropriate secondary reagents to detect Human FLT3. The detection limit for Human FLT3 is 0.078 ng/well. Researchers should empirically determine the suitability of the FLT-3/CD135/FLK-2 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Recombinant Human FLT3 protein
Buffer: This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human FLT3 (rh FLT3; NP_004110.2; Met 1-Asn 541). The IgG fraction of the cell culture supernatant was purified by Protein An affinity chromatography. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing FLT-3/CD135/FLK-2 are readily searchable from our website. Different antibodies against the same target such as FLT-3/CD135/FLK-2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.